1.
Global Rx | Ordering Info
Letaris is an important addition to the limited number of drugs approved for use in the treatment of pulmonary artery hypertension (PAH). ...
2.
Global Rx | In the News
Kuvan increases PAH activity in PKU patients with residual PHA activity. ... Letaris (Ambrosentan)-Gilead-this is an important addition to the limited ...
3.
Global Rx | Ordering Info
Letaris is an important addition to the limited number of drugs approved for use in the treatment of pulmonary artery hypertension (PAH). ...
4.
Global Rx | Ordering Info
Letaris (Ambrosentan). Purpose of Medication and Method of Action. Letaris is an important addition to the limited number of drugs approved for use in the ...
5.
Global Rx | Ordering Info
Letaris is an important addition to the limited number of drugs approved for use in the treatment of pulmonary artery hypertension (PAH). ...
6.
Global Rx
A summary of the business philosophy of GLOABALRx its Aims and Objectives and a list of of the GLOBALRx staff with their backgrounds. ...
7.
Global Rx | Contact Info | Global Rx Staff
He founded GLOBALRx in 1996 with the primary purpose of providing USA-drugs internationally to countries where those drugs were not available. ...
8.
Global Rx
A listing of medications recently approved by the US Food and Drug Administration as well as ... Drugs approved from countries outside of the United States. ...
9.
Global Rx
Established in 1996, is an international speciality pharmacy which provides USA ... pharmacy and does not participate in any on-line prescribing programs. ...
10.
Global Rx | In the News
Solaris (Eculizumab) for Paroxysmal. Alexion Pharmaceuticals — Nocturnal Hemoglobinemia (PNH)-Completed Phase III studies with Solaris have shown a ...